FDA MedWatch Safety AlertsOriginal article
Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
RegulatoryBrevital® SodiumNegative
AI Analysis
Summary
Par Health issued a voluntary nationwide recall of two lots of Brevital® Sodium 500 mg/vial due to the presence of cellulose particulate matter detected in the product. The recall extends to the hospital level.
Outcome Details
Voluntary recall of two lots due to presence of cellulose particulate matter
Importance:5/10
Sentiment:
-0.70
product recallquality controlmanufacturinginjectable drugvoluntary recall
Related Companies
Read the original article
Published by FDA MedWatch Safety Alerts on October 9, 2026 4:00 AM